‘Miracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in small trial. Larger trial is under way.
Studies in The Lancet & The Lancet Haematology show 1st of its kind preventive therapy by Sanofi, using monthly injection 'fitusiran', can reduce bleeding in haemophilia A or B patients.
Hemgenix, manufactured by Australia's CSL Behring, is a one-time therapy, given through a single dose of IV infusion & was approved by US Food and Drug Administration this week.
A poor Muslim man from Kurnool, selling khoya buns during the Medaram Jatara in Telangana, was harassed by some YouTubers and surrounded by a mob over allegations of 'food jihad'.
Indian refiners are testing Venezuelan barrels again as Russian supply sinks, but analysts say volumes will remain limited due to refinery constraints & supply capacity.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS